Synchronous multiple primary lung cancers with different response to gefitinib
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
2005 • 1,510 citations
Mutations of the epidermal growth factor receptor in non-small cell lung cancer – Search and destroy
2005 • 168 citations
Diagnosis and management of synchronous lung cancers
1985 • 162 citations
Special Treatment Issues*
2003 • 107 citations
High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis.
2000 • 84 citations
Molecular analysis of synchronous and metachronous tumors of the lung: Impact on management and prognosis
2001 • 80 citations
Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation
1999 • 64 citations
Synchronous and metachronous lung carcinomas: Molecular evidence for multicentricity
1998 • 59 citations
Patterns of Allelic Loss of Synchronous Adenocarcinomas of the Lung
2005 • 59 citations
Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma
1999 • 42 citations
Clonal Origin of Multiple Lung Cancers
1997 • 32 citations
Redefining Bronchioloalveolar Carcinoma
2005 • 27 citations
Microsatellite Analysis of Synchronous and Metachronous Tumors
2003 • 25 citations
Study of the diagnostic difference between the clinical diagnostic criteria and results of immunohistochemical staining of multiple primary lung cancers.
2003 • 18 citations
Cited By (0)
No citing papers found in database